Career Enhancement Program
Career Enhancement Program
批准号:
10473690
负责人:
KIRSTEN B. MOYSICH
金额:
$19.44万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
未结题
起止时间:
2013-09-18 至 2026-08-31
关键词:
AdvocateApplications GrantsAwardAwarenessBasic ScienceBuffaloesCaliberCancer Research ProjectClinicalClinical ResearchComprehensive Cancer CenterDataData SetDevelopmentDisabled PersonsDiseaseEpidemiologistEthnic groupExtramural ActivitiesFacultyFoundationsFundingFutureGoalsGrantGroup MeetingsHistorically Black Colleges and UniversitiesImmunologistIndividualInstitutesInstitutionInternationalLeadershipMalignant NeoplasmsMalignant neoplasm of ovaryMentorsMentorshipNursing FacultyPatientsPeriodicityPopulation ProgramsPopulation ResearchPostdoctoral FellowProcessRaceRecommendationResearchResearch PersonnelResearch Project GrantsResearch TrainingResource SharingResourcesRunningSeriesSiteSpecimenStructureStudy SectionTalentsTarget PopulationsTissuesTraining ProgramsTranslational ResearchUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesUniversity of Pittsburgh Cancer InstituteWomanWorkanticancer researchcareercareer developmentexperienceinterestmeetingsnext generationnovelpopulation basedprofessorprogramsrecruittranslational cancer researchtranslational impacttumor
中文摘要
罗斯威尔公园卵巢癌孢子职业提升计划(CEP)的目的是
支持初级研究人员在转化性卵巢癌研究中的职业发展。目标是
该计划的对象是优秀的入门级(即助理教授)科学和临床教师,但
在某些情况下,可能包括具有独立工作潜力的高级博士后或临床研究员
从事研究工作。CEP的次要目标是通过以下方式促进卵巢癌研究人员的多样性
鼓励招聘优秀妇女、任职人数不足的少数群体和残疾人。
CEP将得到罗斯威尔公园卵巢癌孢子基金和配套机构的支持
资金来自罗斯威尔公园和罗切斯特大学威尔莫特癌症研究所。CEP作为一个
通过公开和竞争性的申请来确定优秀候选人的结构化机制
审查流程,并将结果获奖者与经验丰富的导师配对。CEP领导人将召开
NIH格式研究部分,并将NIH R21型应用程序分配给两名科学家和一名患者倡导者
评论者。审查结果将在行政核心中汇总,并提交给内部咨询
董事会征集资金建议。成功的申请将获得每年50,000美元的资助
最多两年(总奖金100,000美元)。我们预计每年为四个奖项提供资金,具体取决于资金来源
年。CEP奖获得者将获得罗斯威尔公园卵巢癌孢子核心资源的完全访问权限,
包括组织标本和统计支持。CEP将通过以下方式直接促进职业发展:
一)罗斯威尔公园卵巢癌孢子执行委员会和内部的建设性提案审查
咨询委员会,由具有基础、临床和人口专业知识的有才华的调查人员组成-
基于研究的研究,ii)从具有广泛专业知识的不同教职员工中挑选一名导师进行研究培训
学术生涯发展,以及三)获得发展/充实方案,包括卵巢癌
疾病现场研究小组会议、定期孢子会议、系列研讨会和罗斯威尔公园卵巢
癌症孢子年度休养生息。总而言之,CEP为发展
罗斯威尔公园及其附属机构的下一代转化性卵巢癌研究人员。
英文摘要
The purpose of the Career Enhancement Program (CEP) of the Roswell Park Ovarian Cancer SPORE is to
support the career development of junior researchers in translational ovarian cancer research. The target
population for the program is outstanding entry-level (i.e. Assistant Professor) scientific and clinical faculty, but
in some cases may include senior postdoctoral or clinical fellows with exceptional potential for independent
research careers. A secondary goal of the CEP is to promote the diversity of ovarian cancer researchers, by
encouraging the recruitment of outstanding women, underrepresented minorities and individuals with disabilities.
The CEP will be supported both by the Roswell Park Ovarian Cancer SPORE funds and matching institutional
funds from Roswell Park and the University of Rochester Wilmot Cancer Institute. The CEP serves as a
structured mechanism for identifying outstanding candidates through an open and competitive application and
review process and matching the resulting awardees with experienced mentors. The CEP Leaders will convene
a NIH format study section and assign NIH R21-type applications to two scientific and one patient advocate
reviewers. Review results will be summarized in the Administrative Core and submitted to the Internal Advisory
Board for recommendations for funding. Successful applications will be funded at the level of $50,000 per year
for up to two years (total award $100,000). We anticipate funding four awards per year, depending on the funding
year. CEP awardees will be provided full access to the Roswell Park Ovarian Cancer SPORE Core resources,
including tissue specimens and statistical support. The CEP will directly facilitate career development through:
i) a constructive proposal review by the Roswell Park Ovarian Cancer SPORE Executive Committee and Internal
Advisory Board, which are composed of talented investigators with expertise in basic, clinical, and population-
based research, ii) research training with a mentor chosen from among a diverse faculty with broad expertise in
academic career development, and iii) access to development/enrichment programs, including ovarian cancer
disease site research group meetings, periodic SPORE meetings, seminar series, and Roswell Park Ovarian
Cancer SPORE annual retreats. In summary, the CEP provides a vital mechanism for the development of the
next generation of translational ovarian cancer researchers at Roswell Park and affiliated institutions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel immunological biomarkers ovarian cancer prognosis
-
批准号:8896245
-
项目类别:
-
资助金额:$58.97万
-
财政年份:2015
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Developmental Research Program
-
批准号:10171150
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2013
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Roswell Park Ovarian Cancer SPORE
-
批准号:10171142
-
项目类别:
-
资助金额:$171.61万
-
财政年份:2013
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Developmental Research Program
-
批准号:8485829
-
项目类别:
-
资助金额:$15.76万
-
财政年份:2013
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Developmental Research Program
-
批准号:10473686
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2013
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Roswell Park Ovarian Cancer SPORE
-
批准号:10473654
-
项目类别:
-
资助金额:$153.3万
-
财政年份:2013
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Myeloid Derived Suppressor Cells in Ovarian Carcinogenesis
-
批准号:8485811
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2013
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Career Enhancement Program
-
批准号:10171151
-
项目类别:
-
资助金额:$18.87万
-
财政年份:2013
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Regulatory T Cell Function in Ovarian Cancer
-
批准号:7737007
-
项目类别:
-
资助金额:$56.26万
-
财政年份:2009
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Regulatory T Cell Function in Ovarian Cancer
-
批准号:8268490
-
项目类别:
-
资助金额:$58.71万
-
财政年份:2009
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Regulatory T Cell Function in Ovarian Cancer
-
批准号:8075075
-
项目类别:
-
资助金额:$64.16万
-
财政年份:2009
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Regulatory T Cell Function in Ovarian Cancer
-
批准号:8466716
-
项目类别:
-
资助金额:$54.26万
-
财政年份:2009
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Regulatory T Cell Function in Ovarian Cancer
-
批准号:7871379
-
项目类别:
-
资助金额:$62.95万
-
财政年份:2009
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Pharmacogenetics in Ovarian Cancer
-
批准号:7290917
-
项目类别:
-
资助金额:$9.69万
-
财政年份:2006
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Pharmacogenetics in Ovarian Cancer
-
批准号:7214356
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2006
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Use of Stored Bone Marrow Samples for Pharmacogenetic S*
-
批准号:6888099
-
项目类别:
-
资助金额:$8.44万
-
财政年份:2004
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Pharmacogenetic Studies of Acute Myeloid Leukemia
-
批准号:6795219
-
项目类别:
-
资助金额:$7.81万
-
财政年份:2004
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Myeloid Derived Suppressor Cells in Ovarian Carcinogenesis
-
批准号:8754347
-
项目类别:
-
资助金额:$8.57万
-
财政年份:--
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Developmental Research Program
-
批准号:8918501
-
项目类别:
-
资助金额:$4.89万
-
财政年份:--
-
负责人:KIRSTEN B. MOYSICH
-
依托单位:
Developmental Research Program
-
批准号:8754353
-
项目类别:
-
资助金额:$5.97万
-
财政年份:--
-
负责人:KIRSTEN B. MOYSICH
-
依托单位: